These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30910864)

  • 41. Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.
    Ersek JL; Black LJ; Thompson MA; Kim ES
    Am Soc Clin Oncol Educ Book; 2018 May; 38():188-196. PubMed ID: 30231363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The NCI-MATCH: A National, Collaborative Precision Oncology Trial for Diverse Tumor Histologies.
    Murciano-Goroff YR; Drilon A; Stadler ZK
    Cancer Cell; 2021 Jan; 39(1):22-24. PubMed ID: 33434511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
    Albin N; Mc Leer A; Sakhri L
    Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of the COVID-19 Pandemic on Oncology Clinical Research in Latin America (LACOG 0420).
    Lara Gongora AB; Werutsky G; Jardim DL; Nogueira-Rodrigues A; Barrios CH; Mathias C; Maluf F; Riechelmann R; Fraga M; Gomes H; William WN; Yamada CAF; de Castro G; Rosa DD; de Melo AC; Sala R; Bustamante E; Bretel D; Arrieta O; Cardona AF; Bastos DA
    JCO Glob Oncol; 2021 Apr; 7():649-658. PubMed ID: 33956499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical Trials.
    Yee LM; McShane LM; Freidlin B; Mooney MM; Korn EL
    Cancer J; 2019; 25(4):254-263. PubMed ID: 31335389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Precision oncology using a clinician-directed, tailored approach to molecular profiling.
    Lam M; Tran B; Beck S; Tie J; Herath D; Whittle J; Kwan EM; Fox SB; Fellowes A; Ananda S; Lipton L; Gibbs P; Rosenthal MA; Desai J
    Asia Pac J Clin Oncol; 2018 Feb; 14(1):84-90. PubMed ID: 29083093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small molecules, big impact: 20 years of targeted therapy in oncology.
    Bedard PL; Hyman DM; Davids MS; Siu LL
    Lancet; 2020 Mar; 395(10229):1078-1088. PubMed ID: 32222192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. National Cancer Institute Basket/Umbrella Clinical Trials: MATCH, LungMAP, and Beyond.
    Chen AP; Eljanne M; Harris L; Malik S; Seibel NL
    Cancer J; 2019; 25(4):272-281. PubMed ID: 31335391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
    Nadauld LD; Ford JM; Pritchard D; Brown T
    Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast Cancer.
    Zardavas D; Piccart-Gebhart M
    Am Soc Clin Oncol Educ Book; 2015; ():e183-90. PubMed ID: 25993171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lung cancer as a paradigm for precision oncology in solid tumours.
    Schallenberg S; Merkelbach-Bruse S; Buettner R
    Virchows Arch; 2017 Aug; 471(2):221-233. PubMed ID: 28730537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Precision Cancer Trials With Immunomodulatory Agents: Personalizing Histology Agnostic Approaches.
    Baretti M; Azad NS
    Cancer J; 2019; 25(4):287-295. PubMed ID: 31335393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted therapy: a potential oversight in trial protocol.
    Moorthy T
    Lancet Oncol; 2018 Sep; 19(9):e439. PubMed ID: 30191846
    [No Abstract]   [Full Text] [Related]  

  • 55. The Globalization of Cooperative Groups.
    Valdivieso M; Corn BW; Dancey JE; Wickerham DL; Horvath LE; Perez EA; Urton A; Cronin WM; Field E; Lackey E; Blanke CD
    Semin Oncol; 2015 Oct; 42(5):693-712. PubMed ID: 26433551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OncoCTMiner: streamlining precision oncology trial matching via molecular profile analysis.
    Xu Q; Liu Y; Sun D; Huang X; Li F; Zhai J; Li Y; Zhou Q; Qian N; Niu B
    Database (Oxford); 2023 Nov; 2023():. PubMed ID: 37935585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Promise and the Reality of Genomics to Guide Precision Medicine in Pediatric Oncology: The Decade Ahead.
    Evans WE; Pui CH; Yang JJ
    Clin Pharmacol Ther; 2020 Jan; 107(1):176-180. PubMed ID: 31563145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Basket Trials and the MD Anderson Precision Medicine Clinical Trials Platform.
    Said R; Tsimberidou AM
    Cancer J; 2019; 25(4):282-286. PubMed ID: 31335392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on 'preclinical and early-phase clinical pharmacology'.
    Leonetti A; Boyd L; Giuliani J; Giovannetti E; Garajová I
    Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1033-1036. PubMed ID: 31633383
    [No Abstract]   [Full Text] [Related]  

  • 60. Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.
    Fang J; Cai C; Wang Q; Lin P; Zhao Z; Cheng F
    CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):177-187. PubMed ID: 28294568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.